Mood & Depression · 2 min · 9 questions
PHQ-9: Patient Health Questionnaire-9
Nine questions about the last two weeks. About 2 minutes. Your answers stay on your device.
Medical disclaimer: this is a validated screening questionnaire, not a diagnostic test. Only a qualified health professional can diagnose a condition. Your answers are processed in your browser and are never sent or stored.
Over the last 2 weeks, how often have you been bothered by any of the following problems?
PHQ-9 result
Answer all 9 questions for a complete result. Current partial score shown.
Your responses suggest few or no depressive symptoms over the past two weeks.
Recommended next steps
- No treatment typically indicated.
- Keep supportive routines: sleep, movement, social connection.
- Re-screen if your mood changes or symptoms appear.
Answer the remaining questions to enable the report:
- PHQ-9:
Screening result only, not a diagnosis. Share it with a doctor or therapist.
PHQ-9 scoring guide
| Score | Interpretation | Suggested action |
|---|---|---|
| 0–4 | None / Minimal | No treatment typically indicated. |
| 5–9 | Mild | Watchful waiting; repeat PHQ-9 in 2–4 weeks. |
| 10–14 | Moderate | Schedule an appointment with a doctor or mental health professional. |
| 15–19 | Moderately Severe | Seek a clinical evaluation soon — ideally within the next week. |
| 20–27 | Severe | Contact a healthcare provider promptly for evaluation. |
Clinical background
What it measures
Each of the nine items maps to a DSM criterion for major depressive disorder: anhedonia, depressed mood, sleep, fatigue, appetite, self-worth, concentration, psychomotor change and thoughts of death or self-harm, rated over the past two weeks.
Validity
In the original primary-care validation (Kroenke et al., 2001; n = 6,000), a score of 10 or more had 88% sensitivity and 88% specificity for major depression. It is also widely used to monitor treatment response over time.
Reference: Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.